[{"Assets_0_Q3_USD":290765271.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-874029.0,"NetIncomeLoss_1_Q3_USD":1121167.0,"NetIncomeLoss_3_Q3_USD":1755706.0,"StockholdersEquity_0_Q3_USD":5000001.0,"Ticker":"CELU","CIK":"1752828","name":"GX ACQUISITION CORP.","OfficialName":"Celularity Inc. Class A Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1622347796.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191113"}]